Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

Uncontrolled HIV could be behind COVID-19 variants in Africa

Failure to get COVID-19 vaccines to countries with high rates of uncontrolled advanced HIV could lead to the emergence of new variants, write Nokukhanya Msomi, Richard Lessells and colleagues in a Comment in this week's Nature. ...

HIV & AIDS

New therapeutic target for HIV identified

Scientists in Montreal and London have identified the key role played by transcription factor RORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.

HIV & AIDS

Transgender people continue to face high burden of HIV worldwide

A new analysis highlights the prevalence of HIV among transgender individuals worldwide, and shows the need for continued prevention efforts for this population. Sarah Stutterheim and colleagues of Maastricht University in ...

HIV & AIDS

Researchers develop model for treating HIV/AIDS, depression

Today, people living with HIV/AIDS can remain healthy if they are able to engage in routine care and take the medicines that reduce their virus to undetectable levels. But for people with HIV who are also struggling with ...

HIV & AIDS

HIV rates fall among gay white Americans, but not minorities

(HealthDay)—Some progress has been made in the U.S. fight against HIV, with new infections falling among white gay and bisexual men over the past decade. But their Black and Hispanic counterparts did not see that advance, ...

HIV & AIDS

Fauci says COVID diverted resources from fighting AIDS

Dr. Anthony Fauci, the top U.S. infectious disease expert, said Tuesday the COVID-19 pandemic has diverted scientific and financial resources from the fight against AIDS, seriously impeding global efforts to achieve the U.N. ...

HIV & AIDS

AIDS timeline: Four decades but still no silver bullet

With hopes of eradicating AIDS badly hit by the coronavirus pandemic, we look at the fight against the deadly condition since its emergence 40 years ago, as the planet marks World AIDS Day on Wednesday.

HIV & AIDS

How inequality drives HIV in adolescent girls and young women

Despite the advances that have been made against HIV, the world has 37 million people living with HIV. And 680,000 people died from AIDS-related causes in 2020. While the prevention of mother to child transmission, and provision ...

Medications

New study provides insights into how drug resistance evolves

In the late 1980s, when HIV treatments were first introduced, patients would often develop resistance to those treatments within six months. The introduction of triple-drug treatment regimens in the 1990s was intended to ...

Medical research

Study of HIV prevalence among key populations in Europe

Marking World AIDS Day on 1 December, Eurosurveillance has published an article that brings together evidence on HIV seroprevalence in five population groups affected by HIV in the countries of the European Union and European ...

HIV & AIDS

How far away is help? Researchers map access to HIV care

In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5 million people with HIV live more than 60 minutes from a healthcare facility, according to a new study published ...